
Tailored Treatment Using Combined Tissue and Liquid Biopsies Enhances Patient Outcomes Compared to Individual Approaches
Patients battling advanced solid tumors have shown notably improved survival rates when their treatment was guided by genomic alterations identified in both tissue and liquid biopsies, reveals compelling new data from the phase II ROME trial. Presented at …